The trademark application CELYAD ONCOLOGY was filed by Celyad Oncology, a corporation established under the laws of the Kingdom of Belgium (the "Applicant"). The application was published for oppositions on December 1, 2020, and it was registered by office on March 10, 2021 without any oppositions.
The application was filed in English (French was selected as the second language).
Change of name and professional address of the trademark registration was recorded on August 22, 2024.
Goods And Services
The mark was filed in class 5 with following description of goods:
Cellular pharmaceutical preparations for medical use
Implants comprised of living tissues, for pharmaceutical use
Pharmaceutical products
CAR-T cells (Chimeric Antigen Receptors) for medical use
Compositions comprised of white blood cells (T-cells and NK-cells) for pharmaceutical use
Viral vectors (biological cultures) for medical use
Plasmids (DNA molecules) for medical use.
The mark was filed in class 10 with following description of goods:
Bioreactors for medical analyse
Apparatus for culture, proliferation and modification of human cells
Apparatus for cell therapy
Catheters
Surgical and medical instruments
Medical artificial implants.
The mark was filed in class 42 with Scientific and technological services and research services in the field of cell therapy, oncology, immuno-oncology and in the field of medical and surgical instruments..